Amgen Inc. Underwriting Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated August 15, 2022, by and among the Company and BofA Securities, Inc., Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC and Deutsche Bank...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated February 15, 2023, by and among the Company and Citigroup Global Markets Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC and Mizuho Securities...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2023
Underwriting Agreement, dated February 17, 2022, by and among the Company and BofA Securities, Inc., Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and Goldman Sachs &...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated August 5, 2021, by and among the Company and Citigroup Global Markets Inc., Morgan Stanley & Co. LLC, Barclays Capital Inc. and Goldman Sachs & Co....
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated as of May 4, 2020, by and among the Company and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Morgan Stanley &...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2020
Underwriting Agreement, dated February 18, 2020, by and among the Company and Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Barclays Capital Inc. and Morgan Stanley &...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2020
Underwriting Agreement, dated October 31, 2017, by and among the Company and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BNP Paribas Securities Corp., as...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2017
AMGEN INC. $300,000,000SENIOR FLOATING RATE NOTES DUE 2019 $300,000,000 SENIOR FLOATING RATE NOTES DUE 2020 $700,000,000 1.900% SENIOR NOTES DUE 2019 $700,000,000 2.200% SENIOR...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2017
AMGEN INC. $750,000,0001.850% SENIOR NOTES DUE 2021 $750,000,000 2.250% SENIOR NOTES DUE 2023 $1,250,000,000 2.600% SENIOR NOTES DUE 2026 $1,000,000,000 4.400% SENIOR NOTES DUE...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2016
AMGENINC. 1,250,000,000 1.250% SENIOR NOTES DUE 2022 750,000,000 2.000% SENIOR NOTES DUE 2026 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2016
AMGENINC. $750,000,000 2.125% SENIOR NOTES DUE 2020 $500,000,000 2.700% SENIOR NOTES DUE 2022 $1,000,000,000 3.125% SENIOR NOTES DUE 2025 $1,250,000,000 4.400% SENIOR NOTES DUE...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2015
AMGENINC. $850,000,000 1.250% SENIOR NOTES DUE 2017 $1,400,000,000 2.200% SENIOR NOTES DUE 2019 $1,400,000,000 3.625% SENIOR NOTES DUE 2024 $600,000,000 SENIOR FLOATING RATE NOTES...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2014
AMGEN INC. $1,250,000,000 2.125% SENIOR NOTES DUE 2017 $750,000,000 3.625% SENIOR NOTES DUE 2022 $1,000,000,000 5.375% SENIOR NOTES DUE2043 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2012
AMGEN INC. $1,000,000,000 1.875% SENIOR NOTES DUE 2014 $1,000,000,000 2.50% SENIOR NOTES DUE 2016 $1,750,000,000 3.875% SENIOR NOTES DUE 2021 $2,250,000,000 5.15% SENIOR NOTES...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2011
AMGEN INC. $750,000,000 2.30% SENIOR NOTES DUE 2016 $1,000,000,000 4.10% SENIOR NOTES DUE 2021 $1,250,000,000 5.65% SENIOR NOTES DUE 2042 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2011
AMGEN INC. $900,000,000 3.45% SENIOR NOTES DUE 2020 $600,000,000 4.95% SENIOR NOTES DUE 2041 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
2010
AMGEN INC. $1,000,000,000 5.70% SENIOR NOTES DUE 2019 $1,000,000,000 6.40% SENIOR NOTES DUE 2039 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
2009
AMGEN INC. $500,000,000 6.15% SENIOR NOTES DUE 2018 $500,000,000 6.90% SENIOR NOTES DUE 2038 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
2008